We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Consensus and Guidelines · October 11, 2021

Refining Neoadjuvant Therapy Clinical Trial Design for Muscle-Invasive Bladder Cancer Before Cystectomy

Nature Reviews. Urology

 

Additional Info

Nature Reviews. Urology
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop
Nat Rev Urol 2021 Sep 10;[EPub Ahead of Print], E Chang, AB Apolo, R Bangs, S Chisolm, V Duddalwar, JA Efstathiou, KB Goldberg, DE Hansel, AM Kamat, PG Kluetz, SP Lerner, E Plimack, T Prowell, H Singh, D Suzman, EY Yu, H Zhang, JA Beaver, R Pazdur, C Weinstock, MD Galsky

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading